{
  "pmcid": "11523430",
  "abstract": "2. A 300-word version\n\nTitle: Randomised Controlled Trial on Varicose Vein Management Guidelines\n\nBackground: Varicose veins affect millions worldwide, causing discomfort and complications. This study aimed to update clinical practice guidelines for managing varicose veins.\n\nMethods: A multisociety and multispecialty writing group conducted a systematic review and meta-analysis to develop evidence-based guidelines. The study included a comprehensive literature review up to January 31, 2023, using databases such as Ovid MEDLINE and Cochrane Library. The guidelines were graded using the GRADE method.\n\nParticipants: The study focused on patients with lower extremity varicose veins (CEAP Class C2 disease).\n\nIntervention: The guidelines addressed prevention and management strategies, including compression, medications, and nutritional supplements, as well as treatment of varicose tributaries and management of complications.\n\nObjective: To provide updated, evidence-based guidelines for the management of varicose veins.\n\nOutcome: The primary outcome was the development of comprehensive guidelines for varicose vein management, measured over the study period.\n\nRandomisation: Not applicable.\n\nBlinding: Not applicable.\n\nNumber randomised: Not applicable.\n\nNumber analysed: Not applicable.\n\nResults: The guidelines provided strong and weak recommendations, ungraded consensus statements, and good practice statements. The recommendations were based on systematic reviews and expert consensus.\n\nHarm: Not applicable.\n\nInterpretation: The updated guidelines offer a comprehensive approach to managing varicose veins, aiding practitioners in delivering evidence-based care.\n\nTrial registration: Not applicable.\n\nFunding: Not specified.",
  "word_count": 219
}